Richon VM, Zhou X, Rifkind RA, Marks PA.
Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers.
Blood Cells Mol Dis. 2001 Jan-Feb;27(1):260-4.
Please login to recommend the paper.
No Available Comments
To make a comment you must login or register.